Fairman Group’s CryoPort CYRX Stock Holding History

Fairman Group’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7	Closed	-$57	–	363
2024 Q3	$57	Hold	7	–	–	﹤0.01%	397
2024 Q2	$48	Hold	7	–	–	﹤0.01%	398
2024 Q1	$124	Hold	7	–	–	﹤0.01%	389
2023 Q4	$108	Buy	+7	New	+$91	﹤0.01%	385

Other funds holding CYRX

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

TAM

Thematics Asset Management Paris, France $2.2B AUM 18.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Fairman Group's CYRX Position: Q4 2024 in Review

Fairman Group sold out of CryoPort (CYRX) in Q4 2024, closing a stake of 7 shares — an estimated $57 sold.

Fairman Group first reported a position in CYRX in Q4 2023 and held it in 4 quarters. The position peaked at $124 in Q1 2024. 161 funds tracked by Wall St. Rank hold CYRX as of Q4 2024.

Fairman Group reported no remaining CryoPort position as of Q4 2024 after selling out during the quarter.
Fairman Group sold 7 CryoPort shares in Q4 2024, an estimated $57.
Fairman Group first reported a position in CryoPort in Q4 2023 and held it in 4 quarters.
Fairman Group's CryoPort position peaked at $124 in Q1 2024.
161 funds tracked by Wall St. Rank held CryoPort as of Q4 2024.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.